Extraction socket grafting using  Recombinant human bone morphogenetic protein-2 -Clinical implications and histological observations.

Objectives: –The main indication for preserving osseous structures following tooth extraction has been the rehabilitation of edentulous ridges to facilitate the placement of dental implants. Recombinant Bone Morphogenetic Protein-2(rhBMP-2) is exploited for bone augmentation due to its osteoinductive capacity. This study aimed to determine the effectiveness of bone induction for implant placement by rhBMP-2 delivered on beta-tricalcium phosphate graft (β-TCP) and PRF following tooth extraction. Results: - At three months following socket grafting, minimal changes in the crestal bone width compared to baseline values were seen. A bone loss of 0.6 ± 0.13 mm and 0.5 ± 0.13 mm at the mesiodistal and buccolingual aspects, respectively, was seen. While drilling before the implant placement, the bone's clinical hardness evaluated through tactile was analogous to drilling into spruce or white pine wood. Complete radiographic bone fill was seen in 3 months, and there was no need for any additional augmentation during implant placement. Besides, histology revealed no residual bone particulate graft. Therefore, the data from this study demonstrated that the novel combination of rhBMP-2 +β-TCP mixed with PRF has an effect on de novo bone formation and can be recommended for socket grafting before implant placement.